ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
ObjectivesEstrogen is proven to promote the malignant behaviors of many cancers via its receptors. Estrogen receptor alfa 36 (ER-α36) is a newly identified isoform of estrogen receptor alfa (ER-α), the role of ER-α36 in regulating the effects of estrogen and its potential impact on human cervical ca...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.712849/full |
id |
doaj-1e3feba705d94477853a931b448a922c |
---|---|
record_format |
Article |
spelling |
doaj-1e3feba705d94477853a931b448a922c2021-07-14T12:32:43ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-07-011110.3389/fonc.2021.712849712849ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2Chunyan Wang0Tianli Zhang1Kun Wang2Shuo Zhang3Qing Sun4Xingsheng Yang5Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaSchool of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaObjectivesEstrogen is proven to promote the malignant behaviors of many cancers via its receptors. Estrogen receptor alfa 36 (ER-α36) is a newly identified isoform of estrogen receptor alfa (ER-α), the role of ER-α36 in regulating the effects of estrogen and its potential impact on human cervical cancer is poorly understood.MethodsImmunohistochemistry staining was used to evaluate the expression of ER-α36, estrogen receptor alfa 66 (ER-α66) and their prognostic values in cervical cancer. The effects of ER-α36 and ER-α66 on the proliferation and metastasis of cervical cancer were measured in vitro. A xenograft tumor assay was used to study the tumorigenesis role of ER-α36 in vivo. Furthermore, the functional gene at the downstream of ER-α36 was obtained via next-generation sequencing, and the biological functions of high mobility group A2 (HMGA2) in cervical cancer cells were investigated in vitro.ResultsER-α36 was over-expressed in cervical cancer tissues and elevated ER-α36 expression was associated with poor prognosis in cervical cancer patients. High expression of ER-α36 promoted the proliferation, invasion and metastasis of cervical cancer cells mediated by estrogen, while silencing ER-α36 had the opposite effects. Further research showed that HMGA2 was a downstream target of ER-α36 in cervical cancer cells. The oncogenic effect of ER-α36 was attenuated after HMGA2 knockdown.ConclusionsHigh expression of ER-α36 was correlated with a poor prognosis in cervical cancer by regulating HMGA2. ER-α36 could be a prognostic biomarker and a target for cervical cancer treatment.https://www.frontiersin.org/articles/10.3389/fonc.2021.712849/fullcervical cancerER-α36HMGA2proliferationmetastasis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chunyan Wang Tianli Zhang Kun Wang Shuo Zhang Qing Sun Xingsheng Yang |
spellingShingle |
Chunyan Wang Tianli Zhang Kun Wang Shuo Zhang Qing Sun Xingsheng Yang ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2 Frontiers in Oncology cervical cancer ER-α36 HMGA2 proliferation metastasis |
author_facet |
Chunyan Wang Tianli Zhang Kun Wang Shuo Zhang Qing Sun Xingsheng Yang |
author_sort |
Chunyan Wang |
title |
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2 |
title_short |
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2 |
title_full |
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2 |
title_fullStr |
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2 |
title_full_unstemmed |
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2 |
title_sort |
er-α36 promotes the malignant progression of cervical cancer mediated by estrogen via hmga2 |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-07-01 |
description |
ObjectivesEstrogen is proven to promote the malignant behaviors of many cancers via its receptors. Estrogen receptor alfa 36 (ER-α36) is a newly identified isoform of estrogen receptor alfa (ER-α), the role of ER-α36 in regulating the effects of estrogen and its potential impact on human cervical cancer is poorly understood.MethodsImmunohistochemistry staining was used to evaluate the expression of ER-α36, estrogen receptor alfa 66 (ER-α66) and their prognostic values in cervical cancer. The effects of ER-α36 and ER-α66 on the proliferation and metastasis of cervical cancer were measured in vitro. A xenograft tumor assay was used to study the tumorigenesis role of ER-α36 in vivo. Furthermore, the functional gene at the downstream of ER-α36 was obtained via next-generation sequencing, and the biological functions of high mobility group A2 (HMGA2) in cervical cancer cells were investigated in vitro.ResultsER-α36 was over-expressed in cervical cancer tissues and elevated ER-α36 expression was associated with poor prognosis in cervical cancer patients. High expression of ER-α36 promoted the proliferation, invasion and metastasis of cervical cancer cells mediated by estrogen, while silencing ER-α36 had the opposite effects. Further research showed that HMGA2 was a downstream target of ER-α36 in cervical cancer cells. The oncogenic effect of ER-α36 was attenuated after HMGA2 knockdown.ConclusionsHigh expression of ER-α36 was correlated with a poor prognosis in cervical cancer by regulating HMGA2. ER-α36 could be a prognostic biomarker and a target for cervical cancer treatment. |
topic |
cervical cancer ER-α36 HMGA2 proliferation metastasis |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.712849/full |
work_keys_str_mv |
AT chunyanwang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2 AT tianlizhang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2 AT kunwang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2 AT shuozhang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2 AT qingsun era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2 AT xingshengyang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2 |
_version_ |
1721302892808241152 |